MEDVF — Medivolve Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.71m
- CA$0.69m
Annual balance sheet for Medivolve, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.767 | 1.25 | 0.117 | 4.27 | 1.01 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.32 | 2.86 | 55.3 | 11.7 | 0.262 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 2.3 | 4.68 | 55.9 | 16.8 | 1.47 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0 | 8.55 | 0.595 | 0.534 | 0.405 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 2.3 | 19.1 | 59.3 | 18.8 | 2.37 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.316 | 29.1 | 40.5 | 17.7 | 18.2 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 0.316 | 29.1 | 41.5 | 18.5 | 18.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 1.98 | -10 | 17.8 | 0.326 | -15.8 |
| Total Liabilities & Shareholders' Equity | 2.3 | 19.1 | 59.3 | 18.8 | 2.37 |
| Total Common Shares Outstanding |